Vis enkel innførsel

dc.contributor.authorStrand, Hilde
dc.contributor.authorElshaug, Ann Charlott
dc.contributor.authorBernersen, Øyvind
dc.contributor.authorBallangrud, Randi
dc.date.accessioned2023-03-08T08:32:21Z
dc.date.available2023-03-08T08:32:21Z
dc.date.created2022-05-03T12:47:59Z
dc.date.issued2022
dc.identifier.citationBMC Anesthesiology. 2022, 22 .en_US
dc.identifier.issn1471-2253
dc.identifier.urihttps://hdl.handle.net/11250/3056922
dc.description.abstractBackground: Assessment of appropriate anesthetic depth is crucial to prevent harm to patients. Unnecessary deep anesthesia can be harmful, potentially causing acute renal failure, myocardial injury, delirium, and an increased mortality rate. Conversely, too light anesthesia combined with muscle relaxants can result in intraoperative patient awareness and lead to serious psychological trauma. This trial aimed to ascertain the efectiveness of the advisory display SmartPilot View (SPV), as a supplemental measure in the assessment of anesthetic depth in low risk gynecological surgery patients. The hypothesis was that the use of the SPV would increase the precision of assessment, and result in a higher mean arterial pressure. Methods: This trial used a randomized, controlled, single-blind design with a homogeneous sample. Patients undergoing minor, low risk gynecological surgery were randomly assigned to two groups: a test group wherein current standards were supplemented with the advisory display SPV and a control group assessed using only the current standards. Female patients aged between 18 and 75 years with American Society of Anesthesiologists Physical Status Classifcation System scores of 1–3 undergoing planned general anesthesia using the total intravenous anesthetic method, combining propofol and remifentanil, were included. The exclusion criteria included a body mass index≥35 kg/m2 , a history of alcoholism, drug intake afecting propofol and remifentanil dynamics, and inability to consent. The independent sample t-test and chi-square test or Fisher’s exact test were used to assess the statistical signifcance of diferences between the two groups. Results: A total of 114 patients were included in the analysis (test group n=58, control group n=56). No signifcant diferences in the mean arterial pressure, heart rate, bispectral index, extubation delay, or post-anesthesia care unit stay were found between groups. Conclusions: The addition of the advisory display SmartPilot® View to current standards in the evaluation of anesthetic depth had no signifcant efect on the outcome. Trial registration: The trial was registered on January 16th 2019 with ClinicalTrials.gov (ref: NCT03807271).en_US
dc.language.isoengen_US
dc.publisherBioMed Centralen_US
dc.relation.urihttps://bmcanesthesiol.biomedcentral.com/articles/10.1186/s12871-022-01593-w
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleEffectiveness of the advisory display SmartPilot® view in the assessment of anesthetic depth in low risk gynecological surgery patients: a randomized controlled trialen_US
dc.title.alternativeEffectiveness of the advisory display SmartPilot® view in the assessment of anesthetic depth in low risk gynecological surgery patients: a randomized controlled trialen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber8en_US
dc.source.volume22en_US
dc.source.journalBMC Anesthesiologyen_US
dc.identifier.doi10.1186/s12871-022-01593-w
dc.identifier.cristin2020952
dc.relation.projectHelse Sør-Øst RHF: 2018/2176en_US
dc.source.articlenumber57en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal